Motif Bio Share Discussion Threads

[kaur70] 20/3/2019 11:22

Has there been a leak? Lllevel 2 mental

[mally6] 20/3/2019 11:05

Not a chance whatever u say probably hit that target today

[newtothisgame3] 20/3/2019 10:10

MTFB Motif Bio jumps as US FDA agrees to a meeting to discuss new drug application for novel antibiotic iclaprim via @proactive_UK #MTFB #brighterir #AndrewScottTV #CapitalNetwork1

[lionheart69uk1] 20/3/2019 09:36

You are hilarious, telbap. Not a chance the share price will reach 10p this year unless miracles happen, very unlikely.

[telbap] 20/3/2019 09:10

@ppj. Yep bang in the money

[telbap] 20/3/2019 09:09

That's the point of the RNS, to be able to raise.

[telbap] 20/3/2019 09:08

All aboard the skylark, next stop 10p, calling at 15p, 20p, 25p, 30p our final destination £1.00 All aboard!

[mally6] 20/3/2019 08:22

Good news if it was a complete rejection of the drug fda would have refused to meet.likely solution to get approval now

[1savvyinvestor] 20/3/2019 08:05

Surely that's a spike to sell into for remaining holders . Funding required

[blueblood] 20/3/2019 08:00

Risk of FDA not agreeing to meeting removed must be major positive. Hopefully MTFB will be arguing for labelling solution on 3rd May and have experts lined up. Maybe we need a US partner to oil the wheels.....

[pjj71] 20/3/2019 07:26

initial capital raise to see them through to meeting and then more to fund what the fda wants done.. no wonder the iis dumped at 5p... i guess 4p on the cards today

[blueblood] 20/3/2019 07:18

AMP flogged off just over 50% of their preannounced sale now with about 3.25m shares sold in couple of days.

[bountyhunter] 20/3/2019 07:02

Motif Bio PLC Motif Bio Granted Meeting with U.S. FDA

3 May 2019

[buywell2] 18/3/2019 22:30

You asking to be red carded now ?

[lionheart69uk1] 18/3/2019 21:44

Sadly Newbie, Amphion have no idea what they are doing.

[newtothisgame3] 18/3/2019 21:17

18 Mar 2019
Amphion Innovations AMP is an investment company that focuses on helping build companies in the medical and technology sectors.
Motif Bio MTFB – 7.88% stake – an antibiotic developer focusing on diseases caused by drug-resistant bacteria …

[kfhc] 18/3/2019 12:55

Or he was pushed by the major shareholders as the price for what has happened...

[lionheart69uk1] 18/3/2019 08:39

I see that Richard Morgan has just resigned as Interim Chairman to pursue other business interests. Not exactly a positive sign.

[pwhite73] 18/3/2019 07:58

I am not positive on any AIM companies because they all list with the sole intention of fleecing PIs. Whether they make a success of the company or not is another matter. The records show 95% fail. The only thing I can be positive on is the movement of certain shares for a short period of time not the shares themselves.

[blueblood] 18/3/2019 07:47

Which shares are you positive about Whitey? Over the years you have cropped up everywhere continuously posting negative comments on all sorts of companies!

[pwhite73] 18/3/2019 07:42

RNS out but unlike the commentators on LSE Chat I see nothing encouraging in it all. It is never a good sign when any director resigns immediately. AMP still have the remaining 80% of their shares in Motif to sell off. If you buy on that vacuous RNS you could get burnt.

[andrewsr] 16/3/2019 12:58

An FDA approval could be many months away, don't they need a placing and maybe finance to get them through to that stage? It seems unlikely they would present the FDA with the required data within the next few months. I'm surprised they haven't announced either a placing or the application for a meeting with the FDA or both.

[pwhite73] 16/3/2019 08:07

AMP have sold only one fifth of the shares they intend to sell. There is no point in Motif issuing any good news whilst AMP are selling. Sadly I now think this has a long way to fall before any decent news is announced. I'm not convinced they will even attempt a placing until they receive FDA approval. Difficult one to call this.